One Home Health Chart in Eight Gets a Pre-Bill Review. In 2026, Reading All Eight Costs Less Than the Fax Toner

Twelve percent

That is roughly the share of 30-day periods a mid-sized home health agency puts in front of a human reviewer before the claim goes out. Some agencies do better on new admissions and worse on recertifications. Some outsource coding and OASIS review and buy a sample. Almost nobody reads all of them, and the reason has never been that agencies did not want to. The reason is that a 30-day period is 60 to 80 pages of chart, a QA nurse gets through six or eight of them in a day, and a QA nurse costs what a QA nurse costs.

So the standard answer became sampling, and sampling has a known failure mode: it catches the agency's average, and the money is in the outliers.

What the QA nurse is hunting for in those seventy pages

It is a specific and dull list, and everyone in revenue cycle knows it by heart. Is the face-to-face encounter documented, dated within the window, and does the physician's note actually tie the encounter to the reason for home health rather than to a knee that has nothing to do with it. Is there a homebound statement in the clinician's own words instead of a checked box. Is the plan of care signed, and is the signature dated before the claim goes out. Do the visit frequencies on the plan of care match the visits that actually happened, and if not, is there an order for the change. Do the OASIS-E1 functional items agree with what the therapy evaluation says the patient can do, because those items drive the case-mix group and a disagreement between them is exactly what a reviewer circles. Is the primary diagnosis acceptable under the payment model or is it one of the ones that will not group. Was the Notice of Admission filed inside five calendar days of the start of care.

Then there is the one that is pure money: is this period sitting at or just under its low-utilization threshold. A period that falls below the visit count for its group stops paying as a period and starts paying per visit. The gap between those two numbers on one patient is bigger than a month of QA salary.

What changed is the price of reading, not the ability to read

Nothing new happened to what software can understand about a home health chart; what happened is that reading one all the way through went from something like a dollar-plus to something like a dime, so the check you could only afford on a sample is now affordable on every chart, twice a period.

Frontier models are down roughly tenfold from where they were in 2025, capable ones now price around two dollars per million words of material, and high-volume work run on-device costs roughly 90% less again than sending it to the cloud. Translate that into your world: a full 30-day chart is somewhere near 70 pages. Reading it end to end and producing a findings list now costs about the same as one page of fax toner. In 2025 that same read cost more than a dollar, so if you ran it on 300 periods a month twice each it was a real line item and it lost the argument in the budget meeting. It does not lose that argument anymore.

flowchart TD
  A["Start of care, day 1"] --> B["Check 1 on day 4: F2F, homebound wording, NOA filed"]
  B --> C["Check 2 on day 18: visits done vs plan of care, OASIS vs therapy eval"]
  C --> D["Findings list to the clinical manager, not to billing"]
  D --> E{"Anything fixable while the period is still open?"}
  E -->|Yes| F["Chase the signature, the missed ordered visit, the order change"]
  E -->|No| G["Flag for pre-bill hold and coder review"]
  F --> H["Period closes clean, claim drops on time"]
  G --> H

The arithmetic that used to say no

Assumptions, all stated and illustrative: 300 30-day periods a month; average full-period payment $2,050; the same period paid per visit when it lands under its threshold, call it $650; the check runs twice per period, once early and once around day 18.

Read the fourth row carefully, because it contains the only honest version of this argument. The check does not create revenue. It surfaces visits that a physician already ordered and that your schedule already promised, which somebody missed. Chasing those is both a compliance obligation and a payment consequence. Adding visits that were never ordered in order to clear a threshold is a different activity entirely and it has a name, and the name is fraud. If a vendor pitches you the threshold as an optimisation, end the meeting.

Thursday, 4 p.m., in the pre-bill queue

The revenue cycle specialist opens a queue of 41 periods closing this week. Instead of 41 charts, she has 41 short findings lists. Twenty-nine say nothing found. Six say the plan of care signature is outstanding and name the physician's office and the date it was faxed through Forcura, which is the difference between chasing a signature and chasing a mystery. Three say the face-to-face note does not connect the encounter to the home health reason, which goes back to the clinical manager, not to billing. Two say the OASIS functional items and the physical therapy evaluation disagree, and one of those two turns out to be a coding error worth several hundred dollars in the wrong direction — the agency's direction, which is the kind you have to fix before a reviewer finds it.

In the six states running Review Choice, this same list is what your pre-claim review submission gets built from, and the difference between a 90% affirmation rate and a 60% one is almost entirely these seven items. In an audit request, where you have 45 days to respond, the same findings tell you which periods you should be worried about before the reviewer opens the envelope.

The three things it still gets wrong

It reads what is written, which means a beautifully documented chart for a patient who was not actually homebound reads clean. Grounded checking catches contradiction and absence, not fiction. That failure mode belongs to your clinical managers and your medical review policy, and no amount of cheap reading replaces the field supervisory visit.

It is unreliable on handwriting, and this trade still runs on faxed physician orders with a scrawl in the margin. Document readers got much better in the last two years and they will read a printed face sheet perfectly, but if your physician office sends a fifth-generation fax of a handwritten order, expect a human to keep opening those.

And it does not know your intermediary's local coverage habits. Two reviewers in two jurisdictions circle different things. Keep the person on your team who knows which is which; her job changes from reading 41 charts to deciding what to do about 12 findings lists, which is a better use of a nurse who has been doing this for fifteen years.

The smallest way to start is backwards. Take last month's denied and downcoded periods — the list is already in your denials log — and run the check on those charts only. You know the answer for each one; what you are testing is whether the check would have called it, and what else it flags that nobody noticed. That is an afternoon and a few dollars, and it settles the argument better than any demo.

Frequently asked questions

We already pay an outsourced OASIS coding and review company. Does this replace them?

No, and treating it as a replacement is how agencies get in trouble. Coders make judgement calls on sequencing and comorbidity that carry payment and audit consequences. What changes is what reaches the coder: instead of a sample, everything gets a first pass, and the coder's time goes to the periods with something actually wrong in them.

Our charts have patient information in them. How is this allowed?

The same way your billing clearinghouse and your outsourced coder are allowed: a business associate agreement, restricted access, and a log of who read what. Ask any vendor three questions — where the chart is processed, whether anything is retained after the check, and whether your material is used for anything other than your check. If the answers are vague, keep looking.

Twelve percent seems low. We review every recertification.

Plenty of good agencies do. The argument does not change; it just moves. If you already review 100% of recerts, the cheap check goes on the periods you do not review and on the second pass mid-period, which is the window where a missed ordered visit can still be recovered rather than merely regretted.

Will it work on hospice charts too?

Yes, with a different list. There the items are the election statement and the certification of terminal illness dates, the face-to-face before the third benefit period, the HOPE assessment timepoints including the update visits, the interdisciplinary group review interval, and whether the clinical documentation supports the eligibility narrative rather than repeating it.

A note from us

CallSphere does not read charts. What we build are AI voice and chat agents that answer business phone lines and web chat 24/7, take referral and patient calls, and book appointments — the front of the agency, not the back. We mention it here only because a cleaner pre-bill process usually raises the volume of outbound and inbound calls to physician offices and families, and a lot of agencies discover their phone coverage is the next thing that breaks.